BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 197,100 shares, a growth of 164.6% from the November 30th total of 74,500 shares. Currently, 1.7% of the company’s stock are sold short. Based on an average trading volume of 602,900 shares, the days-to-cover ratio is presently 0.3 days.

BioNexus Gene Lab Stock Performance

Shares of BGLC stock traded up $0.03 during trading hours on Friday, hitting $0.27. 216,087 shares of the company were exchanged, compared to its average volume of 680,894. BioNexus Gene Lab has a one year low of $0.21 and a one year high of $3.39. The business’s 50-day simple moving average is $0.31 and its two-hundred day simple moving average is $0.40.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.